| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-05 |